What is Mark Brescia's NPI number?

Mark Brescia's National Provider Identifier (NPI) is 1154537017, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mark Brescia's specialty?

Mark Brescia is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).

Where is Mark Brescia located?

Mark Brescia's practice location on file with NPPES is 1131 Washington St, Hoboken, NJ 07030-5390.

What is Mark Brescia's phone number?

The practice phone number listed in the NPPES registry for Mark Brescia is (201) 659-7700.

Does Mark Brescia accept Medicare?

Mark Brescia is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mark Brescia's NPI active?

Yes — Mark Brescia's NPI (1154537017) is active in the NPPES registry as of the last update on 2023-03-07.

IndividualActiveAccepts Medicare

Mark Brescia, M.D.

NPI 1154537017 · Specialist · Hoboken, NJ

Mark Brescia, M.D. is a Specialist provider in Hoboken, NJ (NPI 1154537017).

Provider details

NPI number: 1154537017
Entity type: Individual
Primary specialty: SpecialistOther Service Providers
Credential: M.D.
Sex: Male
Sole proprietor: Yes
License: 25MA05799960 (NJ)

Practice location

1131 Washington St

Hoboken, NJ 07030-5390

Phone: (201) 659-7700

Fax: (201) 659-7701

Street-level locationGet directions

More NJ providers

Mailing address

1131 Washington St

Hoboken, NJ 07030-5390

Specialties & taxonomies

SpecialistPrimary174400000XLicense 25MA05799960 (NJ)
Other Service Providers

Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(69/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
77 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	40	$104
Screening Papanicolaou Smear; Obtaining, Preparing and Conveyance of Cervical Or Vaginal Smear to LaboratoryQ0091	20	$52
Cervical Or Vaginal Cancer Screening; Pelvic and Clinical Breast ExaminationG0101	17	$46

Typical Medicare-allowed amounts for these services range $46–$104 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	21
Clobetasol Propionate	18
Estradiol	15
Alprazolam	14
Zolpidem Tartrate	13
Valacyclovir Hclbrand: Valacyclovir	12

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$120 across 6 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-05-15
Last updated: 2023-03-07

Frequently asked questions

What is Mark Brescia's NPI number?: Mark Brescia's National Provider Identifier (NPI) is 1154537017, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mark Brescia's specialty?: Mark Brescia is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
Where is Mark Brescia located?: Mark Brescia's practice location on file with NPPES is 1131 Washington St, Hoboken, NJ 07030-5390.
What is Mark Brescia's phone number?: The practice phone number listed in the NPPES registry for Mark Brescia is (201) 659-7700.
Does Mark Brescia accept Medicare?: Mark Brescia is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mark Brescia's NPI active?: Yes — Mark Brescia's NPI (1154537017) is active in the NPPES registry as of the last update on 2023-03-07.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	40	$104
Screening Papanicolaou Smear; Obtaining, Preparing and Conveyance of Cervical Or Vaginal Smear to LaboratoryQ0091	20	$52
Cervical Or Vaginal Cancer Screening; Pelvic and Clinical Breast ExaminationG0101	17	$46

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	21
Clobetasol Propionate	18
Estradiol	15
Alprazolam	14
Zolpidem Tartrate	13
Valacyclovir Hclbrand: Valacyclovir	12

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$120 across 6 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments